#OLMA

Market Wire News

@marketwirenews.com

1 month ago

NEWS: ( NASDAQ: #OLMA ) Olema Oncology Announces Departure of Chief Operating and Financial Officer

GLOBAL Visibility aéPiot - by aePiot.ro

@globalvisibility.bsky.social

1 month ago

better-experience.blogspot.com/2026/01/aepi...

LA #MOUCHE #NOIRE
multi-search-tag-explorer.aepiot.com/advanced-sea...
#VERONIKA #OLMA
headlines-world.com/advanced-sea...
aepiot.com

Market Wire News

@marketwirenews.com

2 months ago

JUST IN: ( NASDAQ: #OLMA ) OLMA Price Target Alert: $45.00. Issued by UBS

Market Wire News

@marketwirenews.com

3 months ago

Just In: ( NASDAQ: #OLMA ) OLMA Price Target Alert: $48.00. Issued by Oppenheimer

Market Wire News

@marketwirenews.com

3 months ago

NEWS: ( NASDAQ: #OLMA ) OLMA Price Target Alert: $43.00. Issued by Jefferies

Market Wire News

@marketwirenews.com

3 months ago

News; ( NASDAQ: #OLMA ) Buy Recommendation Issued On OLMA By Jefferies

Oninvest

@oninvest.bsky.social

3 months ago

Oncology drugmaker Olema triples in a week after latest Roche data eases sector risks – Oninvest Shares of Olema Pharmaceuticals, a small-cap maker of cancer drugs, soared almost 200% last week, November 18-24. Investors were reacting to positive news on clinical trials from Swiss pharma giant ...

📈 #OLMA surged ~200% last week, hitting a near 4-year high after Roche reported “unprecedented” late-stage breast cancer trial results — a therapy with a similar mechanism to Olema’s, easing perceived risk. JPMorgan and Goldman raised targets. Details 👇 en.oninvest.com/article/onco...

Small Cap Strategist

@smcapstrategist.bsky.social

3 months ago

Most searched small-cap stocks, Mon Nov 24th - #ATON #DNN #BITF #DVLT #UUUU #SERV #ONDS #OLMA #NNE #NGD #NAK #GLUE #ESPR #CLSK #BBAI #ARMN #AIRO #AEO #AEHL #AAOI - More: crystalequityresearch.com/most-searche... - #smallcap

Market Wire News

@marketwirenews.com

3 months ago

Just In: ( NASDAQ: #OLMA ) Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference

Market Wire News

@marketwirenews.com

3 months ago

BREAKING NEWS: ( NASDAQ: #OLMA ) OLMA Price Target Alert: $40.00. Issued by Guggenheim

Market Wire News

@marketwirenews.com

3 months ago

Just In: ( NASDAQ: #OLMA ) Olema Pharmaceuticals Inc. (NASDAQ: OLMA) Rises Sharply in 11/20 Early Trading Session

Small Cap Strategist

@smcapstrategist.bsky.social

3 months ago

Most searched small-cap stocks, Wed Nov 19th - #LAC #KZIA #RXRX #QUBT #SGML #SGML #SEMR #EOSE #NUVB #OLMA #DNN #AGIO #PLUG #SGBX #ONDS #IQ #EVH #CEP #CAAS #BORR #AMLX - More: crystalequityresearch.com/most-searche... - #smallcap

StockTitan

@stocktitan.net

3 months ago

Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock Olema Oncology (Nasdaq: OLMA) priced an underwritten public offering of 10,000,000 common shares at $19.00 per share, for gross proceeds of approximately $190.0 million. The company granted underwriters a 30-day option to buy up to an additional 1,500,000 shares at the public offering price, less discounts and commissions. The offering is expected to close on November 20, 2025, subject to customary closing conditions.Book-running managers include TD Cowen, Evercore ISI, Guggenheim Securities, LifeSci Capital, Oppenheimer & Co., and H.C. Wainwright & Co. The offering is made under a shelf registration (Form S-3) declared effective January 15, 2025; final prospectus supplements will be filed with the SEC.

#OLMA Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock

www.stocktitan.net/news/OLMA/olema-oncology...

Small Cap Strategist

@smcapstrategist.bsky.social

3 months ago

Most searched small-cap stocks, Tue Nov 18th - #BITF #CYPH #RXRX #CLSK #EOSE #LAES #LFS #RR #DNN #QUBT #OLMA #PMN #PLUG #ONDS #OBE #LZB #ESPR #CMCT #BTTC #BBAI - More: crystalequityresearch.com/most-searche... - #smallcap

StockTitan

@stocktitan.net

3 months ago

Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced its

#OLMA Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

www.stocktitan.net/news/OLMA/olema-oncology...

Market Wire News

@marketwirenews.com

3 months ago

JUST IN: ( NASDAQ: #OLMA ) OLMA stock: could today's 197% surge be just the beginning?

Market Wire News

@marketwirenews.com

3 months ago

Breaking News: ( NASDAQ: #OLMA ) Olema Pharmaceuticals Inc. (NASDAQ: OLMA) Climbs to New 52-Week High

Stock Master

@stockmaster70.bsky.social

3 months ago

📢 Stocks Trending NOW: #HD #OLMA #BIDU #NET #MDT #CANF #PACS #PDD #KLAR #COIN

StockTitan

@stocktitan.net

4 months ago

Olema Oncology Reports Third Quarter 2025 Financial and Operating Results Olema Oncology (NASDAQ: OLMA) reported third-quarter 2025 results and clinical progress on Nov 10, 2025. Key developments include a clinical trial collaboration with Pfizer to evaluate palazestrant plus atirmociclib, initiation of the OPERA-02 Phase 3 trial of palazestrant with ribociclib in frontline ER+/HER2- metastatic breast cancer, and presented updated Phase 1b/2 palazestrant+ribociclib data at ESMO 2025.Financials: $329.0M in cash, cash equivalents, and marketable securities as of Sept 30, 2025; GAAP net loss of $42.2M for Q3 2025 versus $34.6M year-ago. GAAP R&D was $40.0M for the quarter. Company expects OPERA-01 topline in H2 2026 and to initiate the palazestrant+atirmociclib study in Q4 2025.

#OLMA Olema Oncology Reports Third Quarter 2025 Financial and Operating Results

www.stocktitan.net/news/OLMA/olema-oncology...

StockTitan

@stocktitan.net

4 months ago

Olema Oncology Announces New Data from the Phase 1b/2 Trial of Palazestrant Plus Ribociclib in ER+/HER2- Metastatic Breast Cancer at ESMO 2025 Olema Oncology (Nasdaq: OLMA) reported updated Phase 1b/2 data for palazestrant plus ribociclib in ER+/HER2- advanced or metastatic breast cancer presented at ESMO 2025 on October 20, 2025.Key clinical readouts: in the 120 mg palazestrant cohort (n=56, median follow-up >19 months) median PFS was 15.5 months overall; among patients with prior CDK4/6 inhibitor therapy median PFS was 12.2 months (9.2 months for ESR1 wild-type; 13.8 months for ESR1 mutant). Across 72 patients, the combination showed favorable tolerability, no new safety signals, and no drug-drug interactions. Data support the ongoing Phase 3 OPERA-02 trial in the frontline setting.

#OLMA Olema Oncology Announces New Data from the Phase 1b/2 Trial of Palazestrant Plus Ribociclib in ER+/HER2- Metastatic Breast Cancer at ESMO 2025

www.stocktitan.net/news/OLMA/olema-oncology...

Campo Zeludi

@schreibgarten.bsky.social

4 months ago

Gallus (Heiliger) – Wikipedia

Der Heilige #Gallus starb am 16. Oktober. Heute sind an der #Olma in St. Gallen drei Rinder ausgebüxt, wovon eines vom Wildhüter erschossen wurde. Ob ein Zusammenhang besteht, ist unklar. de.wikipedia.org/wiki/Gallus_... 😇🐄🐄🐄🐻

Grünliberale Schweiz

@grunliberale.bsky.social

5 months ago

🌤️Unterwegs an den "Tag der Gemeinden" an der #OLMA.
Milizarbeit in einem Behördenamt und die guten Umfrageresultate für einen allgemeinen Bürgerdienst Servicecitoyen passen hervorragend zusammen. Ich bin erfreut, dass die Bevölkerung fortschrittlicher denkt als das Parlament.

Barbara Schaffner

@baschaffner.bsky.social

5 months ago

🌤️ Unterwegs an den "Tag der Gemeinden" an der #OLMA.
Milizarbeit in einem Behördenamt und die guten Umfrageresultate für einen allgemeinen Bürgerdienst Servicecitoyen passen hervorragend zusammen. Ich bin erfreut, dass die Bevölkerung fortschrittlicher denkt als das Parlament.

Bergwelt🇨🇭

@bergwelt.me

5 months ago

Ein Blick ins Herz der Alpen: Das wunderbare Wallis Das Wallis ist Heimat der mächtigsten Bergmassive der Alpen. Bergwelt stellt dir den Kanton im Südwesten der Schweiz etwas genauer vor.

Heute hat bei uns in St.Gallen die traditionelle #OLMA begonnen. Gastkanton ist in diesem Jahr das #Wallis. 🏔 Was der Kanton für Outdoor-Fans zu bieten hat und warum «Cholera» dort schmeckt, erfährst du im Bergwelt-Blog.

#Bergwelt #Schweiz #Wandern #Outdoor #Tradition

Renato Kaiser

@renatokaiser.bsky.social

6 months ago

St. Galler sein war immer schon der ultimative Eisbrecher. Jetzt auch dank Chemie in der Wurst 🥳

SOLOSHOW IN ST. GALLEN am 11.9. in der molto bene Grabenhalle.

#renatokaiser #comedy #satire #soloshow #NEU #grabenhalle #stgallen #olma #bratwurst #senf #pfas #ewigkeitschemikalien #hoppsanggallä

StockTitan

@stocktitan.net

6 months ago

Novel Breast Cancer Treatment: Olema and Pfizer Join Forces on Promising Drug Combination Study Phase 1b/2 trial to evaluate palazestrant with Pfizer's atirmociclib in 35 ER+/HER2- metastatic breast cancer patients. Study starts H2 2025, aims to inform Phase 3 trial.

#OLMA Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast Cancer

www.stocktitan.net/news/OLMA/olema-oncology...

StockTitan

@stocktitan.net

7 months ago

Olema Oncology Reports Second Quarter 2025 Financial and Operating Results Olema Oncology (Nasdaq: OLMA) has reported its Q2 2025 financial results and provided key operational updates. The company has selected 90 mg once-daily palazestrant for Part 2 of the OPERA-01 Phase 3 trial and the OPERA-02 Phase 3 trial in combination with ribociclib for breast cancer treatment.Key financial metrics include $361.9 million in cash and equivalents, and a net loss of $43.8 million for Q2 2025, compared to $30.4 million in Q2 2024. R&D expenses increased to $43.9 million, primarily due to a $10 million milestone payment to Aurigene and increased clinical development activities.The company expects to present mature data from the Phase 1b/2 study at ESMO 2025, initiate OPERA-02 in Q3 2025, and report OPERA-01 top-line data in H2 2026.

#OLMA Olema Oncology Reports Second Quarter 2025 Financial and Operating Results

www.stocktitan.net/news/OLMA/olema-oncology...